| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/28/2003 | US6511807 Carbohydrate ligand that specifically binds to a leczyme; nucleic acid sequence encoding a nonclassical MHC class I heavy chain; ability to associate with a beta 2 microglobulin; major histocompatibility complex transplantation molecules |
| 01/28/2003 | US6511806 Methods for cancer prognosis and diagnosis |
| 01/28/2003 | US6511804 Selective assay for determining the identity of live microorganisms in a mixed culture |
| 01/28/2003 | US6511801 HIV-1 group O strain gp160 env precursor protein comprising the amino acid sequence of SEQ ID NO:100 |
| 01/28/2003 | US6511662 Treatment of cytomegalovirus using aminopeptidase N |
| 01/28/2003 | US6511425 Method for the diagnosis of food intolerance |
| 01/28/2003 | US6510811 Method for localizing allantoic fluid of avian eggs |
| 01/28/2003 | US6510743 Reusable in situ concrete test specimen apparatus and method |
| 01/28/2003 | US6510734 Method of assessing the effects of yarn defects on textile fabrics |
| 01/28/2003 | US6510727 Arrangement for the quantitative and qualitative analysis of particles in gases |
| 01/28/2003 | CA2142264C Monitoring method |
| 01/28/2003 | CA2072176C Reagent for coagulating blood |
| 01/28/2003 | CA2072008C Immunologically active proteins from borrelia burgdorferi, related test kits which contain these proteins and are suitable for detecting antibodies in test fluids, and the use of these proteins as vaccines against infections caused by borrelia strains |
| 01/28/2003 | CA2049970C A stable hemoglobin reference solution |
| 01/28/2003 | CA2027714C Method of measurement in biological systems |
| 01/27/2003 | CA2391642A1 Identification and use of molecules implicated in pain |
| 01/27/2003 | CA2391219A1 Identification and use of molecules implicated in pain |
| 01/27/2003 | CA2391216A1 Identification and use of molecules implicated in pain |
| 01/27/2003 | CA2391112A1 Identification and use of molecules implicated in pain |
| 01/26/2003 | CA2394208A1 Removable cover for a glucose meter |
| 01/26/2003 | CA2354202A1 Stone cell determination using fluorescence |
| 01/24/2003 | WO2002008456A2 Method for identifying metastatic tumor cells |
| 01/24/2003 | CA2417128A1 Immunoassay using insoluble carrier particles and reagent therefor |
| 01/24/2003 | CA2416697A1 Method for identifying metastasizing tumor cells |
| 01/23/2003 | WO2003007331A1 Method for calibrating a mass spectrometer |
| 01/23/2003 | WO2003007293A2 Optical disc system and related detecting methods for analysis of microscopic structures |
| 01/23/2003 | WO2003007263A1 Carbon monoxide sensor and method of use |
| 01/23/2003 | WO2003007225A1 System for cotton trash measurement |
| 01/23/2003 | WO2003007177A1 Method and apparatus for identifying components of a system with a response characteristic |
| 01/23/2003 | WO2003006999A2 System and method for aqueous solubility prediction |
| 01/23/2003 | WO2003006996A2 Natural ligand of gpcr chemr23 and uses thereof |
| 01/23/2003 | WO2003006995A2 Method for identifying substances which modulate interleukin 4 (il-4) signaling |
| 01/23/2003 | WO2003006994A1 Fluorescence polarization-based homogenous assay for aflatoxins |
| 01/23/2003 | WO2003006993A2 Gel compositions |
| 01/23/2003 | WO2003006992A1 Optical sensor containing particles for in situ measurement of analytes |
| 01/23/2003 | WO2003006991A1 HADHs AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE |
| 01/23/2003 | WO2003006990A1 Modifiers of the p21 pathway and methods of use |
| 01/23/2003 | WO2003006989A1 Method of quantifying denatured lipoprotein, reagents for quantifying denatured lipoprotein, method of detecting circulatory disease and reagents for detecting circulatory disease |
| 01/23/2003 | WO2003006988A1 Cardiovascular safety assay |
| 01/23/2003 | WO2003006986A1 Apparatus and method for in situ measuring of evaporation from a surface |
| 01/23/2003 | WO2003006985A1 Examination method for diagnosing rheumatoid arthritis and reagent for examination diagnosis |
| 01/23/2003 | WO2003006981A2 Measuring cell for recording the electrical potential of a sample |
| 01/23/2003 | WO2003006980A1 Analyzing apparatus, piercing element integrally installed body for temperature measuring device with analyzing apparatus, and body fluid sampling apparatus |
| 01/23/2003 | WO2003006977A2 Layered composite and micromechanical sensor element, in particular gas sensor element comprising said layered composite |
| 01/23/2003 | WO2003006975A1 Isochoric volumeter |
| 01/23/2003 | WO2003006973A1 System and method for differential protein expression and a diagnostic biomarker discovery system and method using same |
| 01/23/2003 | WO2003006963A1 Monitor and control using mid-infrared spectroscopy for vapor hydrogen peroxide processing technics |
| 01/23/2003 | WO2003006958A1 Long-life conductivity sensor system and method for using same |
| 01/23/2003 | WO2003006956A2 Cell enumeration |
| 01/23/2003 | WO2003006955A1 Method and instrument for measuring mooney viscosity, and method and apparatus for producing polymer |
| 01/23/2003 | WO2003006951A2 System and method of determining proteomic differences |
| 01/23/2003 | WO2003006947A2 Cell-screening assay and composition |
| 01/23/2003 | WO2003006923A2 Method and device for determination of and imaging of an environment subjectively taken to be real by a person |
| 01/23/2003 | WO2003006692A1 Internal calibration standards for electrophoretic analyses |
| 01/23/2003 | WO2003006685A1 Method for obtaining a titrated preparation of algae and resulting titrated preparations |
| 01/23/2003 | WO2003006684A2 Device and method for detecting photosynthesis inhibition |
| 01/23/2003 | WO2003006681A1 Organometallic probe |
| 01/23/2003 | WO2003006678A2 System and method for storing mass spectrometry data |
| 01/23/2003 | WO2003006676A2 Method for immobilizing molecules onto surfaces |
| 01/23/2003 | WO2003006675A2 Methods and devices based upon a novel form of nucleic acid duplex on a surface |
| 01/23/2003 | WO2003006673A2 A nucleic acid encoding a human junctional adhesion protein (jam3) |
| 01/23/2003 | WO2003006668A2 Haptoglobin Derived Antioxidants |
| 01/23/2003 | WO2003006661A2 Transgenic plants expressing cobalamin binding proteins |
| 01/23/2003 | WO2003006646A1 Regulation of human aminopeptidase n |
| 01/23/2003 | WO2003006627A2 Leukemogenic transcription factors |
| 01/23/2003 | WO2003006614A2 UBE2s AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE |
| 01/23/2003 | WO2003006611A2 GPCs AS MODIFIERS OF THE IRRTK AND p21 PATHWAYS AND METHODS OF USE |
| 01/23/2003 | WO2003006603A2 Triple polypeptide complexes |
| 01/23/2003 | WO2003006507A1 Method of preparing antinarcotic shellfish toxin antibody, novel antibody, elisa kit with the use of the antibody and labelled toxin sample prepared by the method |
| 01/23/2003 | WO2003006504A2 Allelic variants of gpr50 |
| 01/23/2003 | WO2003006503A1 Chimeric g protein coupled receptors |
| 01/23/2003 | WO2003006499A2 Survivin interacting protein tpr1 |
| 01/23/2003 | WO2003006493A2 Histidine phosphatase interacting protein with 180kd |
| 01/23/2003 | WO2003006487A2 Modulation of phosphoinositide 3-kinase activity |
| 01/23/2003 | WO2003006482A2 Use of specific t2r taste receptors to identify compounds that block bitter taste |
| 01/23/2003 | WO2003006471A1 Heteroaryl substituted fused bicyclic heteroaryl compounds as gabaa receptor ligands |
| 01/23/2003 | WO2003006447A2 Interaction inhibitors of tcf-4 with beta-catenin |
| 01/23/2003 | WO2003006168A1 Method for treating magnetic particles and biological analysis device using magnets |
| 01/23/2003 | WO2003006104A2 Lymphatic endothelial cells materials and methods |
| 01/23/2003 | WO2003006103A2 Electrical field stimulation of eukaryotic cells |
| 01/23/2003 | WO2003006058A1 Cd25+ differential markers and uses thereof |
| 01/23/2003 | WO2003006057A1 Composition and method for the treatment of disease |
| 01/23/2003 | WO2003006026A1 Combinations for the treatment of inflammatory disorders |
| 01/23/2003 | WO2003005972A2 Method for identifying tolerance in graft recipients |
| 01/23/2003 | WO2003005946A1 Sanitary article for an organism state analysis and a method of an organism state analysis |
| 01/23/2003 | WO2003005905A1 System for point of care diagnosis and/or analysis |
| 01/23/2003 | WO2003005890A2 Affinity biosensor for monitoring of biological process |
| 01/23/2003 | WO2003005888A2 Lipophilin complexes for use in cancer diagnosis and therapy |
| 01/23/2003 | WO2003005812A2 Modulation of metabolism of steroids and xenobiotics |
| 01/23/2003 | WO2003005811A1 Il-18 transgenic animal |
| 01/23/2003 | WO2002097439A3 A differential labelling method |
| 01/23/2003 | WO2002097424A3 Pipe material discrimination |
| 01/23/2003 | WO2002090960A3 A method of measuring the concentration of hydrogen and methane in nitrogen by means of ion mobility spectrometry |
| 01/23/2003 | WO2002090578A9 Methods and means of histone methylation |
| 01/23/2003 | WO2002080842A3 Medicament and method for diagnosing an autoimmune condition_in particular psoriasis |
| 01/23/2003 | WO2002067984A9 Materials and methods for detecting, preventing, and treating hiv and fiv retroviral infection |
| 01/23/2003 | WO2002066978A3 Detection of compounds that modulate inflammatory responses |
| 01/23/2003 | WO2002066975A3 Tissue-based water quality biosensors for detecting chemical warfare agents |
| 01/23/2003 | WO2002066509A3 Treatment involving dkk-1 or antagonists thereof |
| 01/23/2003 | WO2002065893A3 Photochemical amplified immunoassay |